Sort
10,766 grants matching “checkpoint inhibitor”
Leveraging gnotobiotic models to study the gut microbiota and anti-tumor immunity
$102,181Jessica Lynn Fessler · Stanford University · K00 · FY2024 · CA
A New Immune Checkpoint Pathway in Human Bladder Cancer
$101,835Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2025 · CA
Identifying and targeting neoantigens in aggressive salivary carcinomas
$101,802Luc Gordon Trang Morris · Sloan-Kettering Inst Can Research · R01 · FY2021 · DE
Role of polycystin-1 in centrosome duplication and cell cycle control
$101,700Gabriele Luca Gusella · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · DK
In Situ Tumor Vaccination with a Nano-oligo Therapeutic to Induce Whole-body Antitumor Immune Response
$101,639Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2022 · CA
Regulation of the Anaphase-Promoting Complex by the Spindle Checkpoint
$101,631Hongtao Yu · Ut Southwestern Medical Center · R01 · FY2010 · GM
Expanding pharmacological modalities for targeted cancer therapy
$101,247Hojong Yoon · Broad Institute, Inc. · K00 · FY2023 · CA
Project 1: Developing immune checkpoint controlled-release biomaterials for cancer immunotherapy
$101,121Todd D Giorgio · Vanderbilt University Medical Center · U54 · FY2022 · CA
Genome Integrity Through the Cell Cycle in Homeostasis and Cancer
$101,101Zachary Kenneth Mirman · Brigham And Women'S Hospital · K00 · FY2024 · CA
Durvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer
$101,013Arun Rajan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Musculoskeletal Pain Among Breast Cancer Survivors: Through Bio-behavioral and Imaging Lenses
$100,885Yehui Zhu · Massachusetts General Hospital · K00 · FY2022 · CA
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
$100,789Minah Kim · Columbia University Health Sciences · R37 · FY2024 · CA
INTRACELLULAR CA2+ HOMEOSTASIS AND CELLULAR RADIOSENSITIVITY
$100,568Virginia Commonwealth University · P01 · FY2000 · CA
Development of Preventive Strategies and Therapy for HIV Infection
$100,520Robert Yarchoan · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Towards targeting the lymphoma microenvironment
$100,481Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2020 · CA
Cancer Immunology and Immunotherapy Program
$100,411Keith L Knutson · Mayo Clinic Rochester · P30 · FY2020 · CA
Enabling technologies to study how mechanics influence T cell function at the molecular and cellular levels
$100,343Pui-Yan Victor Ma · Brigham And Women'S Hospital · K00 · FY2022 · CA
P21 INDUCTION BY BRCA2
$100,170Mayo Clinic Coll Of Medicine, Rochester · R29 · FY2002 · CA
P21 INDUCTION BY BRCA2
$100,170Mayo Clinic Coll Of Medicine, Rochester · R29 · FY2001 · CA
P21 INDUCTION BY BRCA2
$100,170Mayo Clinic Coll Of Medicine, Rochester · R29 · FY2000 · CA
Flow Cytometry Core
$100,000W Martin Kast · University Of Southern California · P30 · FY2024 · CA
Consolidated Basic Cancer Research Program
$100,000Dario C. Altieri · Wistar Institute · P30 · FY2020 · CA
Joint submission for administrative supplement proposal: HIPAA aligned storage and computing solution
$100,000Majid Kazemian · Purdue University · R35 · FY2021 · GM
Impact of BRCA1-mTORC2 interaction on breast cancer response to DNA damage and ch
$99,893Nicholas Taylor Woods · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2014 · CA
Identifying Genetic Drivers of the Immunosuppressive Tumor Microenvironment in Lung Cancer
$99,870Gurkan Mollaoglu · Icahn School Of Medicine At Mount Sinai · K00 · FY2022 · CA